Cat. No. | Product name | CAS No. |
DCC3799 |
Nsc750212
Novel inhibitor of lipid metabolism, disrupting tubulin polymerization,suppressing monoglycerol metabolism depleting lipids and inhibiting the growth of both lymphoma and RCC both in vitro and in vivo |
|
DCC3800 |
Nsc-77053
The first reported BoNT/E small molecule inhibitor |
77308-57-7 |
DCC3801 |
Nsc-79887
Novel inhibitor of nucleoside hydrolase (NH) |
19056-78-1 |
DCC3802 |
Nsc-80141
Selective inhibitor of HsEg5 |
97027-56-0 |
DCC3803 |
Nsc-84096
Potent inhibitor of endopeptidase activity of botulinum neurotoxin type A light chain (rBoNT/A-LC) |
908813-78-5 |
DCC3804 |
Nsc-8891
Tyrosyl-DNA phosphodiesterase (Tdp1) inhibitor |
21170-34-3 |
DCC3805 |
Nsc-9037
First-in-class probe of Rad6 function, inhibiting Rad6 function and Rad6-Rad18 interaction in the PCNA ubiquitination cascade |
3569-82-2 |
DCC3806 |
nsc-96626
Novel B-Raf(V600E) inhibitor |
27430-18-8 |
DCC3807 |
Nsi-189 Phosphate
Novel stimulator of neurogenesis of human hippocampus-derived neural stem cells in vitro and in vivo. |
1270138-41-4 |
DCC3808 |
Nsmase2-in-1
Novel inhibitor of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases |
|
DCC3809 |
Nsp-116
Novel free radical scavenger, against light-induced photoreceptor cell damage |
|
DCC3810 |
Nti-007
Potent anti-HBV agent, targeting the NTCP-APOA1-HBx-Beclin1-mediated autophagic pathway |
|
DCC3811 |
Ntrc-739
Novel nonpeptide selective ligand for NTS2 |
|
DCC3812 |
Ntrc-808
Novel nonpeptide potent and selective partial agonist of the Neurotensin receptor type 2 (NTS2) |
|
DCC3813 |
Ntrd22
Novel Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43 |
|
DCC3814 |
Ntr-responsive Protac 17-1
The first NTR-responsive PROTAC, incorporating the caging group on the Von Hippel-Lindau (VHL) E3 ubiquitin ligase ligand, efficiently degrading the EGFR protein and subsequently exert antitumor efficacy |
|
DCC3815 |
Ntz-15
Novel potent STAT3 inhibitor, exhibiting much improved in vivo pharmacokinetic parameters in rats and efficacies against proliferations in multiple cancer cell lines |
|
DCC3816 |
Ntz-24
Novel potent STAT3 inhibitor |
69819-42-7 |
DCC3817 |
Ntzdpa
Novel potent and selective non-thiazolidinedione partial Peroxisome_proliferator-activated_receptor>PPARγ agonist, acting as an antibiotic effectively against bacterial persisters |
118414-59-8 |
DCC3818 |
Nu6155
Novel potent CDK2 inhibitor |
|
DCC3819 |
Nuc013
Novel DNA methytransferase inhibitor, be significantly safer and more effective than decitabine in xenograft models of human leukemia and colon cancer |
|
DCC3820 |
Nucc-201177
Novel highly potent and selective MEK4 inhibitor |